FILE:SIAL/SIAL-8K-20070816130149.txt.gz
EVENTS:	Other Events	Financial Statements and Exhibits
TEXT:
ITEM: Other Events
ITEM: Financial Statements and Exhibits
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 
 
 
 
On August 14, 2007 Sigma-Aldrich issued a press release which indicated that the Board of Directors declared a $.115 per share quarterly cash dividend. The dividend is payable on September 14, 2007 to shareholders of record on August 31, 2007. This press release is furnished as Exhibit 99.1.
 
(d)
Exhibits
The following Exhibits are filed with this Current Report on Form 8-K:
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: August 16, 2007
 
 
 
.
 

Exhibit 99.1
 
August 14, 2007
At the Board of Directors meeting held today, the Directors declared a quarterly cash dividend of $.115 per share. The dividend is payable on September 14, 2007 to shareholders of record on August 31, 2007.
Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 36 countries and has 7,700 employees providing excellent service worldwide. We are committed to accelerating our Customers' success through leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit our award-winning web site at
About Sigma-Aldrich:
www.sigma-aldrich.com


